The “Big Five” Canadian banks offer investment funds and include Royal Bank of Canada, Toronto Dominion Bank (TD Canada Trust), Bank of Nova Scotia, Bank of Montreal and Canadian Imperial Bank of Commerce (CIBC). Let’s explore the best place for you to invest.
Latest News
Timing the withdrawal of RRSP savings to minimize your tax hit Sep 13th
Q. I’ve been fully retired since 2018, and living only on government pension (QPP, OAS and GIS). I have some RRSP and TFSA investments, and would like some help with determining when I should start withdrawing funds—and whether I will need to pay tax. I’ll be turning 71 in December 202.... More »
Watch: John Oliver forgives $15 million in medical debt + MORE Jun 6th
In last night’s episode of Last Week Tonight, host John Oliver took aim at the debt collection industry in America, slamming it for careless and sometimes unethical practices. He revealed his show (which has previously illuminated unethical financial practices by payday lenders and television pre.... More »
Questrade vs Wealthsimple 2023 Update: Breaking Down the Differences for Canadian Investor + MORE Jan 11th
Investing can be overwhelming and confusing, with a plethora of options and platforms to choose from. Two of the most popular online investment platforms in Canada are Questrade and Wealthsimple. Each platform offers its own unique features, benefits and drawbacks, and choosing between the two ca.... More »
Brampton man facing fraud charge, 2 lawsuits as alleged real estate deposit scam collapses - CBC May 13th
Brampton man facing fraud charge, 2 lawsuits as alleged real estate deposit scam collapses CBC.... More »
The Crippling Cost of 70% Tax Rates Jan 22nd
Alexandria Ocasio-Cortez’s proposal would smother investment and innovation, leaving America poorer..... More »
Suncor, Total deal points to declining values for oil sands assets
– theglobeandmail.com
Analysts mixed on whether the Canadian firm landed a good buy, or made a questionable move considering crude prices could remain subdued for years
Number of women on Alberta corporate boards lower than national average: report
– canadianbusiness.com
EDMONTON – A report suggests the number of women who sit on corporate boards in Alberta is less than half the national average, although their presence is slowly increasing.
The study commissioned by the Alberta Securities Commission was done by the University of Calgary’s Haskayne School of Business.
It says women make up 6.6 per cent of corporate board members in the province and 8.9 per cent for companies in Alberta listed on the Toronto Stock Exchange.
An Alberta government website says women’s representation on corporate boards in Canada is 14.5 per cent. Catalyst, a non-profit group, estimates women’s share of board seats on Canadian stock index companies at 21 per cent.
Loren Falkenberg, associate dean of research, said the report aims to shed light on Alberta boardrooms in the hope the data will get corporate leaders to think differently about who they hire.
“I think there is room for more women to serve on boards,” she said Tuesday.
The data reflects the large number of energy, mining and other resource industries in Alberta…
The study commissioned by the Alberta Securities Commission was done by the University of Calgary’s Haskayne School of Business.
It says women make up 6.6 per cent of corporate board members in the province and 8.9 per cent for companies in Alberta listed on the Toronto Stock Exchange.
An Alberta government website says women’s representation on corporate boards in Canada is 14.5 per cent. Catalyst, a non-profit group, estimates women’s share of board seats on Canadian stock index companies at 21 per cent.
Loren Falkenberg, associate dean of research, said the report aims to shed light on Alberta boardrooms in the hope the data will get corporate leaders to think differently about who they hire.
“I think there is room for more women to serve on boards,” she said Tuesday.
The data reflects the large number of energy, mining and other resource industries in Alberta…
Markets took a hit on Tuesday from falling commodities prices and the widening scandal around Volkswagen’s emissions fiddle.
The Financial Post’s Jonathan Ratner looks at some of the day’s top business and financial stories.
Turing Pharmaceuticals says will cut price of drug after accused of gouging patients
– canadianbusiness.com
SAN FRANCISCO – The company that sparked an angry backlash after it raised the price of a drug for treating a deadly parasitic infection by more than 5,000 per cent says it will roll back some of the increase.
Turing Pharmaceuticals CEO Martin Shkreli told ABC News on Tuesday that the new price would make Daraprim more accessible, although he did not say what the new price for the drug would be. A spokesman for Turing did not immediately respond to a request for details.
“We’ve agreed to lower the price of Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit,” Shkreli told ABC.
The company obtained rights to sell the drug, the only U.S.-approved treatment for toxoplasmosis, in August. It hiked the price overnight from $13.50 per pill to $750.
Turing had said it would use profits to improve the drug’s formulation and develop new, better drugs for the infection. It also stressed that some patients can get financial aid from the company to obtain the drug…
Turing Pharmaceuticals CEO Martin Shkreli told ABC News on Tuesday that the new price would make Daraprim more accessible, although he did not say what the new price for the drug would be. A spokesman for Turing did not immediately respond to a request for details.
“We’ve agreed to lower the price of Daraprim to a point that is more affordable and is able to allow the company to make a profit, but a very small profit,” Shkreli told ABC.
The company obtained rights to sell the drug, the only U.S.-approved treatment for toxoplasmosis, in August. It hiked the price overnight from $13.50 per pill to $750.
Turing had said it would use profits to improve the drug’s formulation and develop new, better drugs for the infection. It also stressed that some patients can get financial aid from the company to obtain the drug…
